Skip to main content
BHVN logo

Biohaven Ltd.

BHVNNYSEHealthcareBiotechnology

$14.45Today:- (-)1Y −9.88%

As of Oct 26, 2026 close

Market cap
$2.18B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$7.48$18.57
Volume (live)
-
Avg. volume (3M)
3.38M

Biohaven (BHVN) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), Biohaven used $609.44M of cash in operating activities and spent $715.00K on capital expenditures. That left free cash flow of −$610.15M.

Biohaven Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Biohaven Ltd. (BHVN) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2017
Operating Activities
Net Income-738.82-846.42-408.17-570.28-213.80-118.67-528.81-127.19
Depreciation & Amortization9.927.866.911.391.390.070.000.00
Stock Based Compensation112.3671.9628.79193.5665.6429.5054.9713.24
Change in Working Capital1.3616.8124.61-28.601.668.983.323.98
Change in Accounts Payable-6.390.714.875.931.030.223.323.98
Change in Other Working Capital3.538.0427.18-41.340.648.760.00-3.98
Other Operating Activities168.2764.8116.13106.25-0.744.1693.1815.16
Net Cash from Operating Activities-609.44-582.45-331.73-297.69-145.84-75.96-377.33-94.82
Investing Activities
Capital Expenditures-0.72-4.05-3.05-6.07-0.94-2.70-2.53-0.54
Acquisitions0.000.390.00-35.001.880.000.000.00
Purchases of Investments-266.88-0.72-194.12-263.720.000.000.00-6.63
Sales/Maturities of Investments570.00504.36327.000.000.000.000.000.00
Other Investing Activities-1.850.390.000.000.000.00-1.250.13
Net Cash from Investing Activities300.56-244.97129.83-304.790.94-2.70-3.78-7.04
Financing Activities
Debt Repayment250.000.000.00449.130.000.000.000.00
Common Stock Issued191.01677.67247.92284.260.000.000.000.00
Other Financing Activities-1.890.11-36.01483.34138.45152.24434.59209.76
Net Cash from Financing Activities439.12677.77211.91767.60138.45152.24434.59209.76
Summary
Effect of Forex Changes on Cash0.000.08-0.500.430.000.000.000.00
Net Change in Cash130.24-149.589.52165.55-6.4573.5953.48107.90
Cash at Beginning of Period102.54252.12242.6077.0683.519.92264.2523.57
Cash at End of Period232.78102.54252.12242.6077.0683.51317.73131.47
Free Cash Flow-610.15-586.50-334.77-303.76-146.78-78.65-379.87-95.36
Supplemental Disclosures
Interest Paid-0.13--0.11---
Income Taxes Paid--10.44-33.3038.1716.592.76--

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Biohaven Cash Flow

What is Biohaven's free cash flow?

Biohaven had negative free cash flow of $610.15M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of −$609.44M minus $715.00K of capital expenditures.

How much does Biohaven spend on capital expenditures?

Biohaven spent $715.00K on capital expenditures in fiscal 2025, compared with $4.05M a year earlier.

Does Biohaven pay dividends or buy back shares?

Biohaven's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition